We are live on ! Find out more
CA

Continuum Advisory Portfolio holdings

AUM $1.24B
1-Year Est. Return 30.12%
This Fund
S&P 500
This Quarter Est. Return
+9.05%
1 Year Est. Return
+30.12%
3 Year Est. Return
+77.01%
5 Year Est. Return
+84.78%
10 Year Est. Return
AUM
$831M
AUM Growth
+$54.3M
Cap. Flow
-$782K
Cap. Flow %
-0.09%
Top 10 Hldgs %
27.48%
Holding
1,660
New
4
Increased
253
Reduced
141
Closed
1,237

Top Buys

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$4.49M
2
CRM icon
Salesforce
CRM
+$4.36M
3
NEM icon
Newmont
NEM
+$4.31M
4
ULTA icon
Ulta Beauty
ULTA
+$4.31M
5
NBIX icon
Neurocrine Biosciences
NBIX
+$4.19M

Sector Composition

Rank Sector Weight
1 Miscellaneous 61.38%
2 Technology 12.24%
3 Financials 5.07%
4 Healthcare 5.06%
5 Consumer Discretionary 3.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AVGE icon
501
Avantis All Equity Markets ETF
AVGE
$1.23B
-206
Closed -$14.7K
AVNT icon
502
Avient
AVNT
$3.79B
-34
Closed -$1.26K
AVUS icon
503
Avantis US Equity ETF
AVUS
$14.4B
-27
Closed -$2.49K
AVY icon
504
Avery Dennison
AVY
$13.1B
-12
Closed -$2.14K
AWR icon
505
American States Water
AWR
$3.44B
-893
Closed -$70.3K
AXON
506
Axon Enterprise
AXON
$37B
-33
Closed -$17.4K
AYI icon
507
Acuity Brands
AYI
$9.06B
-32
Closed -$8.43K
AZN icon
508
AstraZeneca
AZN
$253B
-442
Closed -$64.9K
BABA icon
509
Alibaba
BABA
$268B
-185
Closed -$24.5K
BAM icon
510
Brookfield Asset Management
BAM
$73.8B
-1,269
Closed -$61.5K
BAPR icon
511
Innovator US Equity Buffer ETF April
BAPR
$414M
-56
Closed -$2.38K
BBH icon
512
VanEck Biotech ETF
BBH
$464M
-1,304
Closed -$205K
BBHY icon
513
JPMorgan BetaBuilders USD High Yield Corporate Bond ETF
BBHY
$620M
-1,065
Closed -$49K
BBJP icon
514
JPMorgan BetaBuilders Japan ETF
BBJP
$19.8B
-22
Closed -$1.24K
BBY icon
515
Best Buy
BBY
$19.3B
-643
Closed -$47.3K
BCO icon
516
Brink's
BCO
$4.5B
-12
Closed -$1.03K
BCRX icon
517
BioCryst Pharmaceuticals
BCRX
$2.09B
-1,668
Closed -$12.5K
BCS icon
518
Barclays
BCS
$85.8B
-549
Closed -$8.43K
BDEC icon
519
Innovator US Equity Buffer ETF December
BDEC
$214M
-741
Closed -$31K
BEN icon
520
Franklin Templeton
BEN
$16.9B
-88
Closed -$1.69K
BEPC icon
521
Brookfield Renewable
BEPC
$5.41B
-328
Closed -$9.16K
BEP icon
522
Brookfield Renewable
BEP
$8.68B
-520
Closed -$11.5K
BFLY icon
523
Butterfly Network
BFLY
$1.95B
-800
Closed -$1.82K
BGRN icon
524
iShares USD Green Bond ETF
BGRN
$504M
-2,370
Closed -$112K
BGS icon
525
B&G Foods
BGS
$261M
-2,000
Closed -$13.7K

Similar funds

Continuum Advisory's Q2 2025 Portfolio in Review

As of Q2 2025, Continuum Advisory held 1,660 positions worth $831M, up 7% from $776M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Continuum Advisory's Q2 2025 filing shows 4 new, 253 increased, 141 reduced and 1,237 closed positions. Its largest new stake was Ulta Beauty: 10,430 shares worth $4.88M. The largest sale was Berkshire Hathaway Class A, an estimated $6.09M.

By sector, the portfolio is most concentrated in Miscellaneous at 61% of assets, up from 61% a quarter earlier, followed by Technology and Financials.

  • Continuum Advisory's largest Q2 2025 buy was Ulta Beauty: 10,430 shares worth $4.88M.
  • Continuum Advisory added most to CVS Health in Q2 2025, an estimated $4.49M increase.
  • Continuum Advisory's biggest Q2 2025 reduction was Berkshire Hathaway Class A, cutting an estimated $6.09M.
  • Continuum Advisory fully exited Hartford Financial Services in Q2 2025, selling an estimated $4.63M.
  • Continuum Advisory's ten largest holdings make up 27% of its $831M portfolio in Q2 2025.
  • Continuum Advisory opened 4 new positions and closed 1,237 in Q2 2025.
  • Continuum Advisory's portfolio value rose 7% quarter-over-quarter to $831M.

Based on Continuum Advisory's 13F filing for Q2 2025, filed 13 Aug 2025.